PXL student follows revolutionary therapy against blindness (Heusden-Zolder)

At 35, he would be completely blind. It was the bleak prospect for Talha Aydin. The 21-year-old student of PXL University of Applied Sciences has been struggling with a hereditary disease of his retina since birth, which means that his vision becomes increasingly poor, so that he can no longer see. But thanks to a revolutionary gene therapy from the university hospital in Ghent, the boy from Heusden-Zolder no longer has to live from day to day. His vision has since stabilized allowing him to pursue his dream of becoming an independent insurance agent.

— .